Dorsomorphin, also known as BML-275 , is a selective small molecule inhibitor of BMP signaling, which promotes cardiomyogenesis in embryonic stem cells. Dorsomorphin reverses the mesenchymal phenotype of breast cancer initiating cells by inhibition of bone morphogenetic protein signaling.
AMPK Inhibitors Related Prodcuts:
Dorsomorphin 2HCl; WZ4003; ON123300; Doxorubicin HCl; GSK690693; MK-3903